Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Wyeth-Deals' returned 2 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Pharmaceutical Research and Development (R&D) - Increasing Efficiency through Information Technology and Externalization   GBI Research, May 2010, Pages: 82 , 2010 Figure 7: Pfizer–Wyeth Deal, Deal Rationale from Wyeth’s Perspective, January 2009 Figure 8: Roche–Genentech Deal, Deal Rationale from Roche’s Perspective, July 2008 Figure 9: Merck–Schering Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs   GBI Research, Sep 2011, Pages: 168 Figure 11: Pfizer–Wyeth Deal, Deal Rationale from Wyeth’s Perspective, January 2009 31 Figure 12: Roche–Genentech Deal, Deal Rationale from Roche’s Perspective, July 2008 32 Figure 13: Merck–Schering Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network